[Results of follow-up on advanced cases of pulmonary tuberculosis converted to negative with rifampicin treatment]. 1972

M Yamamoto, and K Isoe, and H Nakamura, and H Hirose, and S Izumi

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009169 Mycobacterium tuberculosis A species of gram-positive, aerobic bacteria that produces TUBERCULOSIS in humans, other primates, CATTLE; DOGS; and some other animals which have contact with humans. Growth tends to be in serpentine, cordlike masses in which the bacilli show a parallel orientation. Mycobacterium tuberculosis H37Rv
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D012293 Rifampin A semisynthetic antibiotic produced from Streptomyces mediterranei. It has a broad antibacterial spectrum, including activity against several forms of Mycobacterium. In susceptible organisms it inhibits DNA-dependent RNA polymerase activity by forming a stable complex with the enzyme. It thus suppresses the initiation of RNA synthesis. Rifampin is bactericidal, and acts on both intracellular and extracellular organisms. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p1160) Rifampicin,Benemycin,Rifadin,Rimactan,Rimactane,Tubocin

Related Publications

M Yamamoto, and K Isoe, and H Nakamura, and H Hirose, and S Izumi
January 1979, Kekkaku : [Tuberculosis],
M Yamamoto, and K Isoe, and H Nakamura, and H Hirose, and S Izumi
September 1984, Nihon Geka Gakkai zasshi,
M Yamamoto, and K Isoe, and H Nakamura, and H Hirose, and S Izumi
May 1974, Gruzlica i choroby pluc; tuberculosis et pneumonologia,
M Yamamoto, and K Isoe, and H Nakamura, and H Hirose, and S Izumi
January 1969, Giornale italiano delle malattie del torace,
M Yamamoto, and K Isoe, and H Nakamura, and H Hirose, and S Izumi
September 1956, Diseases of the chest,
M Yamamoto, and K Isoe, and H Nakamura, and H Hirose, and S Izumi
July 1973, Gruzlica i choroby pluc; tuberculosis et pneumonologia,
M Yamamoto, and K Isoe, and H Nakamura, and H Hirose, and S Izumi
July 1970, Kekkaku : [Tuberculosis],
Copied contents to your clipboard!